Drug Discovery

26 Aug 2020
- Drug Discovery
- Research & Development
Engitix signs collaboration and licensing agreement with Takeda to develop anti-fibrotic therapies in advanced liver diseases

By PBR Staff Writer

Engitix, a biotechnology company developing a portfolio of programmes in fibrosis and solid tumours using its proprietary human extracellular matrix (ECM) platform, today entered into a licensing and collaboration agreement with Takeda Pharmaceutical Company to discover and develop novel therapeutics for advanced fibrotic liver diseases, including non-alcoholic steatohepatitis (NASH).
26 Aug 2020
Drug Discovery
Research & Development
Sinovac signs agreement with Bio Farma Indonesia for Covid-19 vaccine cooperation

By PBR Staff Writer

Sinovac Biotech, a leading provider of biopharmaceutical products in China, today announced it has signed two agreements in Hainan, China with PT Bio Farma, a leading biopharmaceutical company in Indonesia, for the supply, local production and technology licensing in respect of the CoronaVac, Sinovac’s inactivated vaccine candidate against Covid-19.
26 Aug 2020
Drug Discovery
Research & Development
Acadia buys clinical-stage biotechnology company CerSci Therapeutics

By PBR Staff Writer

Acadia Pharmaceuticals has added novel pain programme to its portfolio with the acquisition of clinical-stage biotechnology company CerSci Therapeutics.
25 Aug 2020
Drug Discovery
Research & Development
Bristol Myers Squibb to buy clinical-stage protein engineering firm Forbius

By PBR Staff Writer

Bristol Myers Squibb (BMS) has signed an agreement to acquire clinical-stage protein engineering company Forbius for an undisclosed sum.
24 Aug 2020
Drug Discovery
Clinical Trials
6000TOCi Sensor

By victoria.smith

Continuous monitoring provides a real-time data advantage over batch or non-continuous methods of total organic carbon (TOC) measurement.
21 Aug 2020
Drug Discovery
Research & Development
AbCellera acquires OrthoMab bispecific platform from Dualogics

By PBR Staff Writer

AbCellera announced the acquisition of the OrthoMab bispecific platform from Dualogics, LLC. (Dualogics).
20 Aug 2020
Drug Discovery
Research & Development
J&J to acquire Momenta Pharmaceuticals for $6.5bn

By PBR Staff Writer

Johnson & Johnson (J&J) has agreed to acquire Momenta Pharmaceuticals, a Massachusetts-based biotech company focused on immune-mediated diseases, in an all-cash deal worth around $6.5bn.
19 Aug 2020
Drug Discovery
Research & Development
Europe’s largest initiative launches to accelerate therapy development for Covid-19

By PBR Staff Writer

CARE (Corona Accelerated R&D in Europe) a new consortium supported by the Innovative Medicines Initiative (IMI) public-private partnership announced its launch today to accelerate the discovery and development of urgently needed medicines to treat SARS-CoV-2, the virus that causes COVID-19.
18 Aug 2020
Drug Discovery
Pre-clinical Studies
BOLD-100 significantly outperforms remdesivir head-to-head in SARS-CoV-2 model

By PBR Staff Writer

Bold Therapeutics, a clinical-stage biopharmaceutical company, recently generated additional data supporting rapid clinical development of BOLD-100 as a novel antiviral.
18 Aug 2020
Drug Discovery
Research & Development
BMS signs $475m deal with Dragonfly Therapeutics for IL-12 programme

By PBR Staff Writer

Bristol Myers Squibb (BMS) has agreed to acquire the global exclusive licensing rights to interleukin-12 (IL-12), an investigational immunotherapy programme from Dragonfly Therapeutics, in a deal worth more than $475m.

Drug Discovery

Research & Development

LEO Pharma to acquire gene therapy company Replay

Ray Therapeutics receives EMA PRIME status for gene therapy

Clinical Trials

Patient Enrollment

US FDA approves Avacta Group’s IND application for AVA6000

AM-Pharma enrols first patients in Covid-19 phase III trial

Regulation

Drug Filing

Viatris files applications in Japan for approval of Effexor to treat GAD

Scholar Rock submits application of SMA therapy to FDA

Production & Sales

Manufacturing

ENCell and Lucy Biotech forge alliance for mesenchymal stem cell therapy

Merck introduces single-use reactor to accelerate ADC manufacturing

Packaging & Supply Chain

Packaging

Gerresheimer at CPHI Frankfurt 2025

Gerresheimer

Suppliers

No data found

Drug Discovery

Engitix signs collaboration and licensing agreement with Takeda to develop anti-fibrotic therapies in advanced liver diseases

Sinovac signs agreement with Bio Farma Indonesia for Covid-19 vaccine cooperation

Acadia buys clinical-stage biotechnology company CerSci Therapeutics

Bristol Myers Squibb to buy clinical-stage protein engineering firm Forbius

6000TOCi Sensor

AbCellera acquires OrthoMab bispecific platform from Dualogics

J&J to acquire Momenta Pharmaceuticals for $6.5bn

Europe’s largest initiative launches to accelerate therapy development for Covid-19

BOLD-100 significantly outperforms remdesivir head-to-head in SARS-CoV-2 model

BMS signs $475m deal with Dragonfly Therapeutics for IL-12 programme

Pharmaceutical Business review is using cookies

Research & Development

Patient Enrollment

Drug Filing

Manufacturing

Packaging

No data found